首页
订购/客服:400-666-5481

SAR-020106

    
98.10%

(R)-5-((8-chloroisoquinolin-3-yl)amino)-3-((1-(dimethylamino)propan-2-yl)oxy)pyrazine-2-carbonitrile

源叶(MedMol)
S87999 一键复制产品信息
1184843-57-9
C19H19N6OCl
382.84676
SAR020106; SAR020106; SAR 020106; SAR20106; SAR20106; SAR 20106.
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S87999-5mg买3赠1
98.10%

¥700.00

4 - - - -
S87999-10mg买3赠1
98.10%

¥1200.00

4 - - - -
S87999-25mg买3赠1
98.10%

¥2200.00

4 - - - -
S87999-100mg
≥98%

¥6600.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC50 of 13.3 nM for human CHK1. SAR-020106 shows excellent selectivity over CHK2. SAR-020106 significantly enhances the cell killing of Gemcitabine and SN38 by 3- to 29-fold in several colon tumor lines and in a p53-dependent fashion. SAR-020106 can enhance antitumor activity with selected anticancer agents
靶点: Chk1:13.3 nM (IC50);Chk
体外研究: SAR-020106 (0.1-1 μM; 23 hours) abrogates an Etoposide-induced S and G2 arrest.
SAR-020106 is capable of abrogating Etoposide-induced cell cycle arrest with an IC50 of 55 nM and 91 nM in HT29 and SW620 cells, respectively. SAR-020106 is relatively nontoxic with a GI50 of 0.48 μM in HT29 and 2 μM in SW620, resulting in an activity index of 8.7 and 22, respectively. SAR-020106 inhibits cytotoxic drug-induced autophosphorylation of CHK1 at S296 and blocks the phosphorylation of CDK1 at Y15 in a dose-dependent fashion.
体内研究: SAR-020106 (40 mg/kg; i.p.; administered on days 0, 1, 7, 8, 14, and 15) in combination with Irinotecan potentiates the antitumor activity in SW620 xenografts Animal Model: Nude mice bearing SW620 xenograft tumors Dosage: 40 mg/kg Administration: I.p.; administered on days 0, 1, 7, 8, 14, and 15 Result: There was a clear decrease in tumor growth associated with the combination with tumors reaching 300% by 12.5 days.
参考文献: 1. Walton MI, et al. The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106. Mol Cancer Ther. 2010;9(1):89-100.
2. Reader JC, et al. Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. J Med Chem. 2011;54(24):8328-8342.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.612 ml 13.06 ml 26.12 ml
5 mM 0.522 ml 2.612 ml 5.224 ml
10 mM 0.261 ml 1.306 ml 2.612 ml
50 mM 0.052 ml 0.261 ml 0.522 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×